Future Directions for Closed Loop Insulin Delivery Systems

Closed loop insulin systems use a glucose sensor and insulin delivery system to maintainthe blood glucose levels in an automated manner. These devices show great promise as apotential treatment option more importantly for Diabetes Mellitus Type 1 but also, DiabetesMellitus Type 2. However these devices face many problems and these need to be solvedbefore a truly clinically applicable form of the device is commercially introduced. Theirefficacy also needs to be improved in certain groups such as children and pregnant women.The literature search was done on two indexes, Google Scholar and PubMed, using meshwords ‘closed loop insulin delivery in diabetes’. All the publications, by various authors,returning to this search, were critically reviewed, assimilated and summarized. This articlepresents this summary of the problems faced by these devices and suggests possiblesolutions for their improvement.

[1]  S. Johnson Health behavior and health status: concepts, methods, and applications. , 1994, Journal of pediatric psychology.

[2]  S. Kalhan,et al.  Glucose turnover and gluconeogenesis in human pregnancy. , 1997, The Journal of clinical investigation.

[3]  Towards an artificial pancreas at home. , 2011, Diabetes & metabolism.

[4]  J. Stockman,et al.  Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study , 2011 .

[5]  Janet M. Allen,et al.  Closed-loop in children with type 1 diabetes: specific challenges. , 2011, Diabetes research and clinical practice.

[6]  Benyamin Grosman,et al.  Continuous Glucose Monitoring Considerations for the Development of a Closed-Loop Artificial Pancreas System , 2011, Journal of diabetes science and technology.

[7]  R. Carney,et al.  Depression and poor glycemic control: a meta-analytic review of the literature. , 2000, Diabetes care.

[8]  R. Hovorka Continuous glucose monitoring and closed‐loop systems , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[9]  Janet M. Allen,et al.  Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes. , 2010, Diabetes technology & therapeutics.

[10]  Stuart A Weinzimer Closed-loop artificial pancreas: current studies and promise for the future , 2012, Current opinion in endocrinology, diabetes, and obesity.

[11]  Janet M. Allen,et al.  Meta-Analysis of Overnight Closed-Loop Randomized Studies in Children and Adults with Type 1 Diabetes: The Cambridge Cohort , 2011, Journal of diabetes science and technology.

[12]  Joost B L Hoekstra,et al.  Patients' Perception and Future Acceptance of an Artificial Pancreas , 2010, Journal of diabetes science and technology.

[13]  Ahmad Haidar,et al.  Closed-Loop Insulin Delivery During Pregnancy Complicated by Type 1 Diabetes , 2011, Diabetes Care.

[14]  D A Butler,et al.  Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. , 2001, The Journal of pediatrics.

[15]  M. Dimatteo,et al.  The Role of Patient Participation in the Doctor Visit: Implications for adherence to diabetes care , 1996, Diabetes Care.

[16]  L. Gonder-Frederick,et al.  Closed-Loop Glucose Control: Psychological and Behavioral Considerations , 2011, Journal of diabetes science and technology.

[17]  Eyal Dassau,et al.  Enhanced 911/Global Position System Wizard: A Telemedicine Application for the Prevention of Severe Hypoglycemia—Monitor, Alert, and Locate , 2009, Journal of diabetes science and technology.

[18]  B. Anderson,et al.  Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. , 1997, The Journal of pediatrics.

[19]  L. Vignati,et al.  Health-Related Quality-of-Life Results From Multinational Clinical Trials of Insulin Lispro: Assessing benefits of a new diabetes therapy , 1997, Diabetes Care.

[20]  Norman Fleischer,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. , 1993 .